This type of cancer is also treated by sorafenib (Nexavar, a small inhibitor of several tyrosine protein kinases, including VEGFR) which also demonstrates therapeutic effects toward un-resectable advanced hepatocellular carcinoma and progressive differentiated radioactive iodine-resistant thyroid carcinoma. This evidence concerns the gene KDR and cancer.